Conventional or endovascular treatment of ongoing mycotic aortic aneurysmal disease?

Kirsten Kuizenga, Michel M.P.J. Reijnen, Ignace F.J. Tielliu, Eric L.G. Verhoeven, Jan J.A.M. Van den Dungen, Clark J. Zeebregts (Corresponding Author)

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)

Abstract

We report a case in which conventional and endovascular exclusion techniques were used to treat ongoing mycotic aortic aneurysmal disease. A 51-year-old man presented with an infrarenal mycotic aortic aneurysm that was excluded and reconstructed with a superficial femoral vein. Two years later, he developed a symptomatic mycotic aneurysm of the descending thoracic aorta, which required emergent treatment with a stent graft. The patient died 5 months later of massive bleeding owing to an aortobronchial fistula deriving from a new thoracic aneurysm proximal to the stent graft. Choices and different modes of treatment are discussed. Endovascular treatment of symptomatic mycotic aortic aneurysm might provide a valid alternative to open repair but may be unsuccessful owing to ongoing infection. In situ replacement using autologous material seems appealing whenever feasible.

Original languageEnglish
Pages (from-to)103-107
Number of pages5
JournalVascular
Volume17
Issue number2
DOIs
Publication statusPublished - 2 Nov 2009
Externally publishedYes

Fingerprint

Infected Aneurysm
Aortic Diseases
Aortic Aneurysm
Thoracic Aorta
Stents
Transplants
Endovascular Procedures
Femoral Vein
Fistula
Aneurysm
Thorax
Therapeutics
Hemorrhage
Infection

Keywords

  • Aneurysm
  • Aortic
  • Endovascular aneursym repair
  • Mycotic
  • Stent graft
  • Superficial femoral vein

Cite this

Kuizenga, K., Reijnen, M. M. P. J., Tielliu, I. F. J., Verhoeven, E. L. G., Van den Dungen, J. J. A. M., & Zeebregts, C. J. (2009). Conventional or endovascular treatment of ongoing mycotic aortic aneurysmal disease? Vascular, 17(2), 103-107. https://doi.org/10.2310/6670.2008.00063
Kuizenga, Kirsten ; Reijnen, Michel M.P.J. ; Tielliu, Ignace F.J. ; Verhoeven, Eric L.G. ; Van den Dungen, Jan J.A.M. ; Zeebregts, Clark J. / Conventional or endovascular treatment of ongoing mycotic aortic aneurysmal disease?. In: Vascular. 2009 ; Vol. 17, No. 2. pp. 103-107.
@article{2e4d7cc70a404539bd748a8e7d3cd580,
title = "Conventional or endovascular treatment of ongoing mycotic aortic aneurysmal disease?",
abstract = "We report a case in which conventional and endovascular exclusion techniques were used to treat ongoing mycotic aortic aneurysmal disease. A 51-year-old man presented with an infrarenal mycotic aortic aneurysm that was excluded and reconstructed with a superficial femoral vein. Two years later, he developed a symptomatic mycotic aneurysm of the descending thoracic aorta, which required emergent treatment with a stent graft. The patient died 5 months later of massive bleeding owing to an aortobronchial fistula deriving from a new thoracic aneurysm proximal to the stent graft. Choices and different modes of treatment are discussed. Endovascular treatment of symptomatic mycotic aortic aneurysm might provide a valid alternative to open repair but may be unsuccessful owing to ongoing infection. In situ replacement using autologous material seems appealing whenever feasible.",
keywords = "Aneurysm, Aortic, Endovascular aneursym repair, Mycotic, Stent graft, Superficial femoral vein",
author = "Kirsten Kuizenga and Reijnen, {Michel M.P.J.} and Tielliu, {Ignace F.J.} and Verhoeven, {Eric L.G.} and {Van den Dungen}, {Jan J.A.M.} and Zeebregts, {Clark J.}",
year = "2009",
month = "11",
day = "2",
doi = "10.2310/6670.2008.00063",
language = "English",
volume = "17",
pages = "103--107",
journal = "Vascular",
issn = "1708-5381",
publisher = "SAGE Publications",
number = "2",

}

Kuizenga, K, Reijnen, MMPJ, Tielliu, IFJ, Verhoeven, ELG, Van den Dungen, JJAM & Zeebregts, CJ 2009, 'Conventional or endovascular treatment of ongoing mycotic aortic aneurysmal disease?' Vascular, vol. 17, no. 2, pp. 103-107. https://doi.org/10.2310/6670.2008.00063

Conventional or endovascular treatment of ongoing mycotic aortic aneurysmal disease? / Kuizenga, Kirsten; Reijnen, Michel M.P.J.; Tielliu, Ignace F.J.; Verhoeven, Eric L.G.; Van den Dungen, Jan J.A.M.; Zeebregts, Clark J. (Corresponding Author).

In: Vascular, Vol. 17, No. 2, 02.11.2009, p. 103-107.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Conventional or endovascular treatment of ongoing mycotic aortic aneurysmal disease?

AU - Kuizenga, Kirsten

AU - Reijnen, Michel M.P.J.

AU - Tielliu, Ignace F.J.

AU - Verhoeven, Eric L.G.

AU - Van den Dungen, Jan J.A.M.

AU - Zeebregts, Clark J.

PY - 2009/11/2

Y1 - 2009/11/2

N2 - We report a case in which conventional and endovascular exclusion techniques were used to treat ongoing mycotic aortic aneurysmal disease. A 51-year-old man presented with an infrarenal mycotic aortic aneurysm that was excluded and reconstructed with a superficial femoral vein. Two years later, he developed a symptomatic mycotic aneurysm of the descending thoracic aorta, which required emergent treatment with a stent graft. The patient died 5 months later of massive bleeding owing to an aortobronchial fistula deriving from a new thoracic aneurysm proximal to the stent graft. Choices and different modes of treatment are discussed. Endovascular treatment of symptomatic mycotic aortic aneurysm might provide a valid alternative to open repair but may be unsuccessful owing to ongoing infection. In situ replacement using autologous material seems appealing whenever feasible.

AB - We report a case in which conventional and endovascular exclusion techniques were used to treat ongoing mycotic aortic aneurysmal disease. A 51-year-old man presented with an infrarenal mycotic aortic aneurysm that was excluded and reconstructed with a superficial femoral vein. Two years later, he developed a symptomatic mycotic aneurysm of the descending thoracic aorta, which required emergent treatment with a stent graft. The patient died 5 months later of massive bleeding owing to an aortobronchial fistula deriving from a new thoracic aneurysm proximal to the stent graft. Choices and different modes of treatment are discussed. Endovascular treatment of symptomatic mycotic aortic aneurysm might provide a valid alternative to open repair but may be unsuccessful owing to ongoing infection. In situ replacement using autologous material seems appealing whenever feasible.

KW - Aneurysm

KW - Aortic

KW - Endovascular aneursym repair

KW - Mycotic

KW - Stent graft

KW - Superficial femoral vein

UR - http://www.scopus.com/inward/record.url?scp=67649784411&partnerID=8YFLogxK

U2 - 10.2310/6670.2008.00063

DO - 10.2310/6670.2008.00063

M3 - Article

VL - 17

SP - 103

EP - 107

JO - Vascular

JF - Vascular

SN - 1708-5381

IS - 2

ER -

Kuizenga K, Reijnen MMPJ, Tielliu IFJ, Verhoeven ELG, Van den Dungen JJAM, Zeebregts CJ. Conventional or endovascular treatment of ongoing mycotic aortic aneurysmal disease? Vascular. 2009 Nov 2;17(2):103-107. https://doi.org/10.2310/6670.2008.00063